In Brief: Obstetrics and Gynecology Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Obstetrics and Gynecology Devices Panel: Slated to discuss two draft guidance documents at a July 14-15 meeting in Rockville, Maryland. On July 14 the panel will discuss a draft guidance document on the study and evaluation of intrapartum continuous monitors for fetal pulse oximeters and fetal tissue pH. On July 15 the panel is scheduled to discuss a draft guidance document on the study and evaluation of in vivo devices for the detection of cervical cancer. For further information, contact FDA's Elisa Harvey at 301/594-1180...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.